Microbiota in health and diseases

被引：1520

作者：

Hou, Kaijian ^{[1
]}

Wu, Zhuo-Xun ^{[2
]}

Chen, Xuan-Yu ^{[2
]}

Wang, Jing-Quan ^{[2
]}

Zhang, Dongya ^{[3
]}

Xiao, Chuanxing ^{[1
]}

Zhu, Dan ^{[1
]}

Koya, Jagadish B. ^{[2
]}

Wei, Liuya ^{[4
]}

Li, Jilin ^{[5
]}

Chen, Zhe-Sheng ^{[2
]}

机构：

[1] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Endocrine & Metab Dis,Longhu Hosp, Shantou 515000, Guangdong, Peoples R China

[2] St Johns Univ, Coll Pharm & Hlth Sci, Inst Biotechnol, Dept Pharmaceut Sci, Queens, NY 11439 USA

[3] Moon Guangzhou Biotech Ltd, Microbiome Res Ctr, Guangzhou 510535, Peoples R China

[4] Weifang Med Univ, Sch Pharm, Weifang 261053, Shandong, Peoples R China

[5] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Cardiovasc, Shantou 515000, Guangdong, Peoples R China

来源：

SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2022年 / 7卷 / 01期

关键词：

CHRONIC KIDNEY-DISEASE; INFLAMMATORY-BOWEL-DISEASE; TRIMETHYLAMINE-N-OXIDE; CLOSTRIDIUM-DIFFICILE INFECTION; HUMAN GUT MICROBIOME; FATTY LIVER-DISEASE; ALL-CAUSE MORTALITY; REGULATORY T-CELLS; P-CRESYL SULFATE; INTESTINAL MICROBIOTA;

D O I：

10.1038/s41392-022-00974-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The role of microbiota in health and diseases is being highlighted by numerous studies since its discovery. Depending on the localized regions, microbiota can be classified into gut, oral, respiratory, and skin microbiota. The microbial communities are in symbiosis with the host, contributing to homeostasis and regulating immune function. However, microbiota dysbiosis can lead to dysregulation of bodily functions and diseases including cardiovascular diseases (CVDs), cancers, respiratory diseases, etc. In this review, we discuss the current knowledge of how microbiota links to host health or pathogenesis. We first summarize the research of microbiota in healthy conditions, including the gut-brain axis, colonization resistance and immune modulation. Then, we highlight the pathogenesis of microbiota dysbiosis in disease development and progression, primarily associated with dysregulation of community composition, modulation of host immune response, and induction of chronic inflammation. Finally, we introduce the clinical approaches that utilize microbiota for disease treatment, such as microbiota modulation and fecal microbial transplantation.

引用

页数：28

共 415 条

[1] Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease [J].